Pharmarise Holdings
Contents
1. 201 3 F2R 1 000 AS UWAL 179 2009 11 PJER800 9 FR200 Pharmarise Holdings Corporation 3 Company Information Session RAE ARE 1 MAA y ELLA neme Mi Py y AARE BARA UE DER gt ji ie Pie lt Pharmarise harmari 29 4 J RIE2. Pharmarise Holdings Corporation Company Information Session 2 Pharmarise HOLDINGS SA 2013 2 ee ee A A 5 203 _ H Jaw JE Lai ia ai MER sos S Tit E SE Pa hi AK PIR VER DT ee N e 3 e a WY WES NERS ANR UE stoca TEI XA 35 7009 9 3 e As po ape Ne 3 IDA AR 03 55 pc ua ci A 201 1 9 1750 201 2 10 2010 3 2010 8 2011 6 0 Pharmarise Holdings Corporation O 5 Company Information Session
3. 7 2012 5 1 3000 2013 5 1 8000 dase ear rns 2 Pharmarise HOLDINGS AIBR 2 iit A z NGELU IE F B ER ao Mo L 2002 8 ES n SONO 19 Sa gt i c i ar Aaaa PAI VU AL QC 2012 6 15 SITE 5 Pharmarise Holdings Corporation 1 Company Information Session Pharmarise HOLDINGS Pharmarise HOLDINGS SAN
4. WER 5 MEWE 7OEE EE
5. M amp A M amp A Pharmarise Holdings Corporation 2 O Company Information Session 3 Pharmarise rad HOLDINGS SAM i 9 40 000 37018 400 E 30 Loc 33018 90 000 20 ee o 10 000 5 0 i wr 2012 2014 2015 5 5 5 SR AE O sas 30 000 22 5 26 01 30 A _ 19 5 0 20 000 Y 20 7 A o 2012 2014 2015 5 5 5 Pharmarise Holdings Corporation 3 O Company Informati
6. Strengths FI 1 1 2 2 y TE 3 4 Weaknesses 5 SWOT 1 O Opportunities MEL i ia 2ERAREDER yyy 2 3 ALA 3 Threats Pharmarise Holdings Corporation Company Information Session CO Prarmacise Pharmarise Holdings Corporation 2 O Company Information Session Pharmarise rad HOLDINGS A A M A 3 ARM o oo HEROE pi ZIZIIZAD p Mics NE
7. i pe ab BA NUERA 1000 1 CF acme 2 37 6 19 1 11 6 3 3 Pharmarise Holdings Corporation 1 2 Company Information Session Z Pharmarise 2 oe eae ee ean
8. 815 34 0 31 8 pr em i a zE i HA MBA B 5 mm ri a Ng 4 2 M amp A 16 BRE S 1115 1618 7 9 6 tas ME 8 10 12 2 H CN O N 201 3 Pharmarise HOLDINGS D y l 2 Pharmarise a XI Ses HOLDINGS FED HO FISNION Pharmarise Holdings Corporation Company Information Session 2 A Pharmarise HOLDINGS BATAN BAREK EM Gi NOI 5 Pharmarise HOLDINGS cm fa amp Hi gt e e 299888393390 RILE 6 ccem
9. 2m1l3 U SB 4 2 2 622 7022 978 2 1952 Pharmarise Holdings Corporation 3 Company Information Session Pharmarise HOLDINGS http www pharmarise com roo eis aii Lo
10. SE TE ibe Pharmarise Holdings Corporation Company Information Session 02 gt e 2 cr Q 9 0 0 ee 0 0 0 Of fu o 6 GG e ee e e e e ee ee ee ee ee e ee e 0 000 je c pO e of 000000000000 ee 06 6 A 6 o AE Ji e bc 000000 e o o o ee R dooyoo voor ojo oo e feeee oe S N Se NN SH N sa E R KN lr 4 b UA 3 Y W e e e e cv ooo a Pharmarise rad HOLDINGS PRI 2011 50 40 50 TT 40 09 1 2011 Pharmarise Holdings Corporation 2 2 Company Information Session A Pharmarise HOLDINGS 5 2 5
11. 413 n 2012 5 2013 5 1 470 25 1 610 9 5 5 0 4 9 685 21 8 1 030 50 2 Pharmarise Holdings Corporation 2 6 Company Information Session ZU Pharmarise EG MN 3 22 gE BY 2013 5 1 1 400 Po PI eed 1 000 6606060606060660 6 0e 000000 00000 0 0 000000 ee 00000 o g e 8s e o Jo 2005 2006 20072 2008 2009 2010 201 1 2012 2013 5 5 5 5 5 5 5 5 5A FE 2011 12 1 3 Pharmarise Holdings Corporation Company Information Session Pharmarise HOLDINGS Hs EY 2 Pharmarise harmari ll Lap
12. Pharmarise HOLDINGS Pharmarise Holdings 2 lt UI A Pharmarise Company Information Ses HOLDINGS Contents 02 AEM O Pharmarise HOLDINGS Z armarise eee Pharmarise Holdings Corporation pg 7164 0011 1 38 1 an pegang A a a RI ORI GN IRI 012 1 815 545 ni 1 131 1 028 ae a i OS ie Sea n da A 2013 1 39 55 38 53 40 Pharmarise Holdings Corporation Company Information Session m A amp Pharmarise 41 DY 19845 1
13. JR 7 9 UR 503 41 Pharmarise HOLDINGS oe ARR VA oes pe Pharmarise O 5 3 O M amp A 10 O O O O 201 1 5 2012 5 ELI A o OA Al 1 343 1 470 ae AA 5 0 5 0 i 62 685 Pharmarise Holdings Corporation 2 5 Company Information Session 2 Pharmari E YE AZ y E eater 2013 5 de e O ee A M amp A 22 5 MT 1 1 m M amp A 3 493 133 2
14. on Session m Z armarise eee HE Pharmarise Holdings Corporation Q Company Information Session emen 11 30 1
Download Pdf Manuals
Related Search